PROCEPT BioRobotics (PRCT) Gross Profit (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Gross Profit data on file, last reported at $53.9 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 22.16% year-over-year to $53.9 million in Q1 2026; TTM through Mar 2026 was $206.0 million, a 31.87% increase from a year earlier, with the FY2025 full-year figure at $196.2 million, up 43.13% from the prior year.
• Gross Profit for Q1 2026 stood at $53.9 million, up from $46.3 million in the prior quarter.
• Over the last five years, Gross Profit for PRCT reached as high as $54.0 million in Q3 2025 and fell as low as $7.7 million in Q1 2022.
• Historically, Gross Profit has averaged $29.1 million across 5 years, with a median of $25.0 million in 2024.
• Across the five-year window, Gross Profit soared 141.3% in 2022 and climbed 6.05% in 2025, its largest moves.
• Year by year, Gross Profit stood at $10.7 million in 2022, then soared by 99.09% to $21.3 million in 2023, then jumped by 105.47% to $43.7 million in 2024, then advanced by 6.05% to $46.3 million in 2025, then advanced by 16.48% to $53.9 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $53.9 million in Q1 2026, $46.3 million in Q4 2025, and $54.0 million in Q3 2025.